Date of issue: 
In the near future increasing number of elderly patients with haematological malignancies will require chemotherapy and/or radiotherapy. The high dose or even standard chemotherapy usually results in higher, than in younger patients, percentage of life-threatening myelosupression and deaths. This phenomenon in elderly patients is not clear. There are reports suggesting that in elderly patients age-related changes are not so different comparing to younger subjects. In elderly patients anti-tumour response is reduced but function of dendritic cells in these patients is preserved. It seems that cell- based immunotherapy might be a promising therapeutic option for age-advanced cancer patients. In this paper we shortly reviewed some age-specific haematological malignancies.
Author of the article: 

The Editorial Board
Andrzej Łukaszyk - przewodniczący, Zofia Bielańska-Osuchowska, Szczepan Biliński, Mieczysław Chorąży, Aleksander Koj, Włodzimierz Korochoda, Leszek Kuźnicki, Aleksandra Stojałowska, Lech Wojtczak

Editorial address:
Katedra i Zakład Histologii i Embriologii Uniwersytetu Medycznego w Poznaniu, ul. Święcickiego 6, 60-781 Poznań, tel. +48 61 8546453, fax. +48 61 8546440, email:

PBK Postępby biologi komórki